Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $2.631B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IWM | iShares TR | 600,000 | $149M | 5.7% | — | — | PUT | 464287655 |
| XBI | SPDR Series Trust | 1,050,000 | $134M | 5.1% | — | — | PUT | 78464A870 |
| AZN | AstraZeneca PLC | 456,031 | $89.94M | 3.4% | — | — | ORD | G0593M107 |
| QQQ | Invesco QQQ TR | 150,000 | $86.58M | 3.3% | — | — | PUT | 46090E103 |
| IBB | iShares TR | 475,000 | $80.2M | 3.0% | — | — | PUT | 464287556 |
| UTHR | United Therapeutics Corp | 80,300 | $47.62M | 1.8% | — | — | PUT | 91307C102 |
| BIIB | Biogen Inc | 229,521 | $42.08M | 1.6% | — | — | COM | 09062X103 |
| CELC | Celcuity Inc | 300,000 | $34.24M | 1.3% | — | — | PUT | 15102K100 |
| AXSM | Axsome Therapeutics Inc. | 200,000 | $33.8M | 1.3% | — | — | PUT | 05464T104 |
| PFE | Pfizer Inc | 800,000 | $22.46M | 0.9% | — | — | CALL | 717081103 |
| GMAB | Genmab A/S | 752,261 | $20.18M | 0.8% | — | — | SPONSORED ADS | 372303206 |
| LQDA | Liquidia Corporation | 500,000 | $18.87M | 0.7% | — | — | PUT | 53635D202 |
| SYK | Stryker Corporation | 44,480 | $14.62M | 0.6% | — | — | COM | 863667101 |
| EXEL | Exelixis Inc | 251,500 | $10.79M | 0.4% | — | — | PUT | 30161Q104 |
| ORIC | Oric Pharmaceuticals Inc | 679,578 | $8.61M | 0.3% | — | — | COM | 68622P109 |
| TNGX | Tango Therapeutics Inc | 395,081 | $8.265M | 0.3% | — | — | COM | 87583X109 |
| TYRA | Tyra Biosciences Inc | 204,015 | $7.814M | 0.3% | — | — | COM | 90240B106 |
| REPL | Replimune Group Inc | 1,015,400 | $7.768M | 0.3% | — | — | CALL | 76029N106 |
| RARE | Ultragenyx Pharmaceutical Inc | 350,000 | $7.332M | 0.3% | — | — | CALL | 90400D108 |
| AXGN | AxoGen Inc | 210,665 | $6.979M | 0.3% | — | — | COM | 05463X106 |
| DFTX | Definium Therapeutics Inc | 344,166 | $6.505M | 0.2% | — | — | COM SHS | 24477V105 |
| CYTK | Cytokinetics Inc | 91,791 | $6.05M | 0.2% | — | — | COM | 23282W605 |
| MANE | Veradermics Inc | 73,315 | $4.63M | 0.2% | — | — | COMMON STOCK | 922967104 |
| HRMY | Harmony Biosciences Hldgs Inc | 152,695 | $4.277M | 0.2% | — | — | COM | 413197104 |
| PCVX | Vaxcyte Inc | 50,600 | $2.94M | 0.1% | — | — | COM | 92243G108 |
| CMPX | Compass Therapeutics Inc | 500,000 | $2.645M | 0.1% | — | — | CALL | 20454B104 |
| TENX | Tenax Therapeutics Inc | 104,400 | $1.669M | 0.1% | — | — | COM | 88032L605 |
| SEPN | Septerna Inc | 47,506 | $1.142M | 0.0% | — | — | COM | 81734D104 |
| OKUR | Onkure Therapeutics Inc | 141,700 | $587K | 0.0% | — | — | COM CL A | 68277Q105 |
| ZYME | Zymeworks Inc | 1,610 | $40,314 | 0.0% | — | — | COM | 98985Y108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 3,145,888 (+3676.6%) | $65.91M (+3340.0%) | 2.5% | — | — | COM | 90400D108 |
| BMY | Bristol-Myers Squibb Co | 1,988,721 (+31.4%) | $121M (+47.8%) | 4.6% | — | — | COM | 110122108 |
| AXSM | Axsome Therapeutics Inc. | 212,747 (+1634.4%) | $35.96M (+1505.1%) | 1.4% | — | — | COM | 05464T104 |
| INSM | Insmed Inc | 346,075 (+120.7%) | $56.59M (+107.4%) | 2.2% | — | — | COM PAR $.01 | 457669307 |
| ALC | Alcon AG | 729,972 (+119.5%) | $55M (+109.9%) | 2.1% | — | — | ORD SHS | H01301128 |
| SUPN | Supernus Pharmaceuticals | 954,309 (+72.5%) | $49.33M (+79.4%) | 1.9% | — | — | COM | 868459108 |
| NKTR | Nektar Therapeutics | 509,546 (+16.2%) | $36.66M (+97.7%) | 1.4% | — | — | COM | 640268306 |
| UTHR | United Therapeutics Corp | 160,070 (+1.5%) | $94.92M (+23.6%) | 3.6% | — | — | COM | 91307C102 |
| XENE | Xenon Pharmaceuticals Inc | 305,216 (+409.5%) | $17.75M (+561.1%) | 0.7% | — | — | COM | 98420N105 |
| CELC | Celcuity Inc | 366,175 (+22.3%) | $41.8M (+40.0%) | 1.6% | — | — | COM | 15102K100 |
| COGT | Cogent Biosciences Inc | 2,113,551 (+7.1%) | $81.35M (+16.0%) | 3.1% | — | — | COM | 19240Q201 |
| RYTM | Rhythm Pharmaceuticals Inc | 450,096 (+65.8%) | $39.14M (+34.7%) | 1.5% | — | — | COM | 76243J105 |
| IDYA | IDEAYA Biosciences Inc | 1,131,786 (+27.9%) | $37.71M (+23.2%) | 1.4% | — | — | COM | 45166A102 |
| BMRN | BioMarin Pharmaceutical Inc | 781,982 (+12.2%) | $44.17M (+6.6%) | 1.7% | — | — | COM | 09061G101 |
| IMNM | Immunome Inc | 1,701,904 (+5.2%) | $37.22M (+7.1%) | 1.4% | — | — | COM | 45257U108 |
| PHVS | Pharvaris N V | 818,328 (+9.8%) | $23.12M (+11.8%) | 0.9% | — | — | COM | N69605108 |
| WVE | Wave Life Sciences Ltd | 189,253 (+19.6%) | $1.372M (-49.0%) | 0.1% | — | — | SHS | Y95308105 |
| MIRM | Mirum Pharmaceuticals Inc | 27,591 (+19.4%) | $2.549M (+39.7%) | 0.1% | — | — | COM | 604749101 |
| DXCM | Dexcom Inc | 393,576 (+4.1%) | $24.72M (-1.5%) | 0.9% | — | — | COM | 252131107 |
| IMTX | Immatics N.V | 3,630,454 (+5.7%) | $35.72M (-1.0%) | 1.4% | — | — | SHS | N44445109 |
| SVRA | Savara Inc | 364,763 (+19.7%) | $1.992M (+8.4%) | 0.1% | — | — | COM | 805111101 |
| ESTA | Establishment Labs Hldgs Inc | 33,930 (+19.6%) | $1.927M (-6.8%) | 0.1% | — | — | COM | G31249108 |
| SLNO | Soleno Therapeutics Inc | 14,689 (+18.3%) | $492K (-14.4%) | 0.0% | — | — | COM | 834203309 |
| ACAD | Acadia Pharmaceuticals Inc | 78,551 (+19.8%) | $1.749M (-0.2%) | 0.1% | — | — | COM | 004225108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AZN | ASTRAZENECA PLC | 1,632,334 | $150M | 5.7% | — | — | — | 046353108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 164,594 | $74.62M | 2.8% | — | — | — | 92532F100 |
| ABBV | ABBVIE INC | 317,783 | $72.61M | 2.8% | — | — | — | 00287Y109 |
| ISRG | INTUITIVE SURGICAL INC | 126,968 | $71.91M | 2.7% | — | — | — | 46120E602 |
| LLY | ELI LILLY & CO | 61,652 | $66.26M | 2.5% | — | — | — | 532457108 |
| RNAM | AVIDITY BIOSCIENCES INC | 745,116 | $53.75M | 2.0% | — | — | — | 05370A108 |
| APGE | APOGEE THERAPEUTICS INC | 534,845 | $40.37M | 1.5% | — | — | — | 03770N101 |
| — | CIDARA THERAPEUTICS INC | 180,265 | $39.82M | 1.5% | — | — | — | 171757206 |
| GKOS | GLAUKOS CORP | 288,128 | $32.53M | 1.2% | — | — | — | 377322102 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,104,274 | $27.62M | 1.0% | — | — | — | 152309100 |
| GEHC | GE HEALTHCARE TECHNOLOGIES I | 160,876 | $13.2M | 0.5% | — | — | — | 36266G107 |
| EXAS | EXACT SCIENCES CORP | 101,443 | $10.3M | 0.4% | — | — | — | 30063P105 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 527,099 | $6.367M | 0.2% | — | — | — | 03237H101 |
| MASI | MASIMO CORP | 46,201 | $6.009M | 0.2% | — | — | — | 574795100 |
| QURE | UNIQURE NV | 176,513 | $4.224M | 0.2% | — | — | — | N90064101 |
| EVMN | EVOMMUNE INC | 153,320 | $2.625M | 0.1% | — | — | — | 30054Y107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 598,327 (-37.7%) | $113M (-30.7%) | 4.3% | — | — | SHS USD | G50871105 |
| BBIO | BridgeBio Pharma Inc | 409,183 (-43.2%) | $30.39M (-44.9%) | 1.2% | — | — | COM | 10806X102 |
| PRAX | Praxis Precision Medicines Inc | 63,680 (-49.3%) | $20.52M (-44.6%) | 0.8% | — | — | COM | 74006W207 |
| DYN | Dyne Therapeutics Inc | 1,633,897 (-27.5%) | $29.62M (-32.8%) | 1.1% | — | — | COM | 26818M108 |
| INBX | Inhibrx Biosciences Inc | 406,029 (-10.7%) | $27.3M (-24.0%) | 1.0% | — | — | COM | 45720N103 |
| CMPX | Compass Therapeutics Inc | 2,056,161 (-38.9%) | $10.88M (-39.8%) | 0.4% | — | — | COM | 20454B104 |
| RCUS | Arcus Biosciences Inc | 923,086 (-15.8%) | $19.94M (-23.7%) | 0.8% | — | — | COM | 03969F109 |
| IRON | Disc Medicine Inc | 78,320 (-29.4%) | $5.008M (-43.2%) | 0.2% | — | — | COM | 254604101 |
| ROIV | Roivant Sciences Ltd | 477,995 (-34.9%) | $13.24M (-16.9%) | 0.5% | — | — | SHS | G76279101 |
| EWTX | Edgewise Therapeutics Inc | 386,498 (-11.7%) | $12.17M (+12.1%) | 0.5% | — | — | COM | 28036F105 |
| ANAB | AnaptysBio Inc | 248,253 (-13.7%) | $13.77M (-1.3%) | 0.5% | — | — | COM | 032724106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTRA | Natera Inc | 1,550,280 | $310M | 11.8% | — | — | COM | 632307104 |
| VERA | Vera Therapeutics Inc | 2,793,987 | $112M | 4.3% | — | — | CL A | 92337R101 |
| BIOA | BioAge Labs Inc | 2,293,788 | $40.12M | 1.5% | — | — | COM | 09077V100 |
| AVBP | Arrivent BioPharma Inc | 1,696,752 | $39.14M | 1.5% | — | — | COM | 04272N102 |
| RAPP | Rapport Therapeutics Inc | 1,904,408 | $59.59M | 2.3% | — | — | COM | 75383L102 |
| NXTC | Nextcure Inc | 222,654 | $2.378M | 0.1% | — | — | COM | 65343E207 |
| BOLT | Bolt Biotherapeutics Inc | 137,721 | $556K | 0.0% | — | — | COM | 097702203 |
| JBIO | Jade Biosciences Inc | 107,391 | $1.509M | 0.1% | — | — | COM | 008064206 |
| IMA | ImageneBio Inc | 31,884 | $159K | 0.0% | — | — | COM | 45175G207 |